Skip Navigation LinksHome > July 2010 - Volume 32 - Issue 5 > Retrospective Study on the Combination of Desferrioxamine an...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181e015b0
Clinical and Laboratory Observations

Retrospective Study on the Combination of Desferrioxamine and Deferasirox for Treatment of Iron-overloaded Thalassemic Patients: First Evidence of More Than 2 Years

Jetsrisuparb, Arunee MD; Komvilaisak, Patcharee MD; Wiangnon, Surapon MD; Jetsrisuparb, Charoon MD

Collapse Box


Some iron-overloaded patients have problems being treated with iron chelators. We therefore retrospectively studied 7 iron-overloaded thalassemic patients. Within the same week, patients received 20 to 30 mg/kg/d of oral deferasirox for 4 consecutive days, then a subcutaneous infusion of 20 to 40 mg/kg/d of desferrioxamine for 8 to 12 hours on the next 3 consecutive days. The median treatment duration was 25 months (range, 8 to 32). All of the patients showed a decrease in serum ferritin without any side effects. The protocol, combining deferasirox and desferrioxamine in sequence, was effective and safe: more cases should be studied.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.